|
1
|
Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN.
|
Cancer Res
|
1999
|
1.95
|
|
2
|
Temporal events in skin injury and the early adaptive responses in ultraviolet-irradiated mouse skin.
|
Am J Pathol
|
2000
|
1.22
|
|
3
|
Assessment of the biological and pharmacological effects of the alpha nu beta3 and alpha nu beta5 integrin receptor antagonist, cilengitide (EMD 121974), in patients with advanced solid tumors.
|
Ann Oncol
|
2007
|
1.19
|
|
4
|
Retracted
Targeting EGFR in bladder cancer.
|
World J Urol
|
2007
|
0.99
|
|
5
|
Transcription factor AP-2alpha is preferentially cleaved by caspase 6 and degraded by proteasome during tumor necrosis factor alpha-induced apoptosis in breast cancer cells.
|
Mol Cell Biol
|
2001
|
0.95
|
|
6
|
Killing of immature CD4+ CD8+ thymocytes in vivo by anti-CD3 or 5'-(N-ethyl)-carboxamide adenosine is blocked by glucocorticoid receptor antagonist RU-486.
|
Eur J Immunol
|
1993
|
0.88
|
|
7
|
Correlation between cytosolic Ca2+ concentration and cytotoxicity in hepatocytes exposed to oxidative stress.
|
Toxicology
|
1988
|
0.87
|
|
8
|
Generation of natural killer cells from both Fc gamma RII/III+ and Fc gamma RII/III- murine fetal liver progenitors.
|
Blood
|
1993
|
0.82
|
|
9
|
Inhibition of I-Ad-, but not Db-restricted peptide-induced thymic apoptosis by glucocorticoid receptor antagonist RU486 in T cell receptor transgenic mice.
|
Eur J Immunol
|
1996
|
0.80
|
|
10
|
Resistance to tumor necrosis factor-induced apoptosis in mouse fibroblasts is a genetically dominant phenotype.
|
Int J Oncol
|
1996
|
0.75
|
|
11
|
Cycloheximide-induced apoptosis in melanoma cells derived from regressing cutaneous tumours of Sinclair swine.
|
J Comp Pathol
|
1996
|
0.75
|
|
12
|
Concurrent education for a building program.
|
Hosp Prog
|
1967
|
0.75
|